Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

In Vitro Fertilization Market Share

ID: MRFR//1682-CR | 80 Pages | Author: Kinjoll Dey| October 2018

The Radiopharmaceutical Market is a dynamic and rapidly evolving sector within the healthcare industry. Companies in this sphere adopt several market share positioning strategies to establish a competitive advantage and benefit from the rising need for diagnostics-and therapeutics that use radiopharmaceuticals.
So, a wide range of radiopharmaceutical companies promotes continuous research and development to produce innovative drugs for the market. Such technology would enable companies to distinguish themselves, thereby attracting healthcare providers who require advanced diagnostics and therapies.
As a market share positioning strategy, creating strategic partnerships and collaborations is significant. Companies commonly form partnerships with research institutes, academic centers and other industrial partners in order to obtain expertise, pool resources as well as widen their product ranges. Such partnerships help expand market penetration and promote a cooperative approach towards the resolution of intricate yet daunting healthcare issues.
The growth into new geographical territories is essential for radiopharmaceutical companies wishing to increase the size of their market. By focusing on unattended areas and securing an effective presence in the market, firms can take advantage of a rapidly growing interest for nuclear medicine uses.
The tailoring of appropriate marketing strategies and educational programs is a prerequisite for success in the radiopharmaceutical market. Companies spend on knowledge dissemination to healthcare professionals who, in turn... Customized marketing campaigns also help to meet specific regional needs and preferences.
In the radiopharmaceutical industry, compliance to rigid regulatory standards and observing quality standard is not an option but a must. Companies that focus on regulatory compliance and implement quality assurance programs enhance their competitive position through the manufacture of products with proven safety attributes to secure confidence among health professionals and patients.
The diversification of the product portfolio is an anxiety to respond appropriately for various condition. As a consequence, radiopharmaceutical companies usually spend their money to diversify the set of viable radiotracers for specific diseases or condition and as such increase market share while addressing diverse needs of medical practitioners.
Deploying patient access programs is a compassionate and tactical measure to increase market share. Participating with healthcare providers and insurers in raising patient access to radiopharmaceuticals, companies will maintain a large number of patients and strengthen their market position while contributing to better outcomes for the patients.
Achieving cost-effectiveness in manufacturing and optimizing supply chain management is critical for sustaining competitiveness. Companies that can produce high-quality radiopharmaceuticals efficiently and ensure a reliable supply chain are better positioned to meet market demands and maintain favorable pricing structures.

Global In Vitro Fertilization Market Overview


In Vitro Fertilization Market size was valued USD 21.4 Billion in 2021 and is expected to reach USD 34.9 Billion by 2030 at CAGR of 5.7% during the forecast period 2024-2030. High average conception age and robust regulatory frameworks are the key market drivers enhancing the market growth.


In Vitro Fertilization Market Overview


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


In Vitro Fertilization Market Trends



  • Growing Prevalence of robust regulatory framework to boost market growth


These have been a major concern that are attempted to be addressed by the medical fraternity. The root cause of the same can be traced back to delayed pregnancies lead to the risk of infertility and pregnancy related problems. The growth of assisted reproductive technologies, such as embryo culture media market, has been made possible by the availability of appropriate regulatory frameworks. However, in poorer nations, their penetration is still comparatively sluggish.


Further, the worldwide in vitro fertilization industry has seen a dramatic increase in the average age of first time mothers. This tendency is attributed, according to estimates, to better contraceptive methods and the rising number of women who choose to put off having children.


As per the data published by Australian Institute of Health and welfare 2021, the average age of first-time mothers increased from 27.9 years in 2009 to 31.9 years in 2019. The average age for first-time mothers growing, an increasing number of women are expected to face problems in conceiving naturally. In this scenario, a growing number of women are forced to opt for IVF treatments, such medical treatments for conceiving or to be first-time mothers has enhanced the market CAGR across the globe in the recent year.


In Vitro Fertilization Market Segment Insights


In Vitro Fertilization Type Insights


The market segments of in vitro fertilization, based on type, includes intrauterine insemination, intracytoplasmic sperm injection, and Ivf using donor eggs. The intrauterine insemination in vitro fertilization segment held the majority share in 2022 contribution in respect to the in vitro fertilization market revenue. This is primarily owing to the rising prevalence of delayed marriages and opt for artificial fertilization across the globe. For instance, as per the World Health Organization (WHO), globally 8%-10% of couples suffer from infertility which is approximate 80 billion couples worldwide.


In Vitro Fertilization Devices Insights


The in vitro fertilization market segmentation, based on devices, includes imaging systems, sperm separation system, ovum aspiration pump, micromanipulator, and cryosystem. All the devices uniformly perform in the market and is projected to be the faster-growing segment during the forecast period, 2024-2030. This is due to the increasing preference for IVF devices to become parents. Hence, rising use of these devices for In Vitro Fertilization positively impacts the market growth.


In Vitro Fertilization Reagents Insights


The in vitro fertilization market data has been bifurcated by reagents into embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. The embryo culture media segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2030. Increasing population and decreasing fertility rate, increasing awareness about in vitro fertilization, and high disposable income are the factors due to which the embryo culture media segment grow in the near future.


2021:Hamilton Thorne Ltd. received FDA approval for the GYNEMED GM501, in US and Europe a ready-to-use medium has designed for in vitro washing and handling procedures of human oocytes and embryos. This approval has further broadened the growth opportunity for the in vitro fertilization industry.


Figure 1: In Vitro Fertilization Market, by Surgery, 2022 & 2030 (USD billion)In Vitro Fertilization Market, by Surgery, 2022 & 2030 (USD billion)


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


In Vitro Fertilization End User Insights


Based on End Users, the in vitro fertilization industry has been segmented into clinical research institutes, fertility clinics, and hospitals. Fertility clinics held the largest segment share in 2022, owing to the rapid adoption of advanced in vitro fertilization products. Moreover, increasing government initiatives to aware about in vitro fertilization and high disposable income is expected to bolster the market of in vitro fertilization during the assessed timeline.


The fastest growing segment in the in vitro fertilization industry is hospitals. Increased availability and accessibility of possible treatments can be recognized to an increased preference for hospitals for infertility treatments.


In Vitro Fertilization Regional Insights


By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America in vitro fertilization market accounted for USD 10.76 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to a lesser birthrate, which linked to various socioeconomic influences across the region.


Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: In vitro fertilization market share by region 2022 (%)IN VITRO FERTILIZATION MARKET SHARE BY REGION 2022 (%)


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe in vitro fertilization market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the in vitro fertilization, and trained and experienced faculty. Further, the Germany market of in vitro fertilization held the largest market share, and the UK market of in vitro fertilization was the fastest growing market in the European region


The Asia-Pacific in vitro fertilization Market is expected to grow at the fastest CAGR from 2024 to 2030. This is due to increased mounting medical tourism in the region for IVF. Moreover, China market of in vitro fertilization held the largest market share.


For instance, India market of in vitro fertilization is the favored destination for medical travelers due to the availability of surgeons, lenient legal measures and regulatory necessities, cutting-edge technology, & cost-effective treatments, India’s fertility centers can provide more patient-oriented therapies. On the other hand, Singapore is famous for the presence of well-trained doctors, state-of-the-art facilities, and quality care. Hence, Asia-Pacific is anticipated to register the highest growth rate over the forecast period from 2024–2030.


In Vitro Fertilization Key Market Players & Competitive Insights


Major market players are spending a lot of money on R&D to increase their product lines, which will help the market growth of in vitro fertilization. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the in vitro fertilization industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.


One of the primary business strategies adopted by manufacturers in the in vitro fertilization industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, in vitro fertilization industry has provided medicine with some of the most significant benefits. The in vitro fertilization market major player such as Cooper Surgical Fertility, Cook Medical, Oxford Gene Technology, Merck KGaA, INVO Bioscience, Thermo Fisher Scientific, Genea Limited, Irvine Scientific, Vitrolife GENEA BIOMEDIX, and others are working to expand the market demand by investing in research and development activities.


FUJIFILM Irvin Scientific, Inc. a world leader in the development, innovation, and producer of cell culture media, medical devices for clinical and researchers, and reagents. The company delivers unrivalled service and quality to scientists working in the industrial cell culture, regenerative medicine, assisted reproductive technology and cytogenetic, cell therapy for the large-scale production of vaccines and biotherapies. For Instance: In September 2019, FUJIFILM Irvin Scientific, Inc. launched Vit Kit-NX, a new vitrification solution for IVF. Vit Kit-NX is a compatible with open and closed vitrification devices, ready-to-use solution to deliver high quality media that are flexible and effective to streamline IVF laboratory processes.


Key Companies in the market of In Vitro Fertilization market includes



  • Cooper Surgical Fertility

  • Cook Medical

  • Oxford Gene Technology

  • Merck KGaA

  • INVO Bioscience

  • Thermo Fisher Scientific

  • Genea Limited

  • Irvine Scientific

  • Vitrolife GENEA BIOMEDIX, among others


In Vitro Fertilization Industry Developments


April 2022:On fast Company’s 2022 list of the most innovative biotech firms, MRW Life Sciences, the first automated platform to protect frozen eggs and embryos essential to in vitro fertilization (IVF), came in first place. TMRW’S technology provided digital identification and traceability of eggs and embryos as well as process automation, enhancing safety and transparency, and replacing antiquated systems.


2021: Cooper Surgical join hands with Virtus Health to reinforce its fertility technology, to increase the accessibility of advanced treatment to infertile couples.


In Vitro Fertilization Market Segmentation


In Vitro Fertilization Type Outlook



  • Intrauterine Insemination

  • Intracytoplasmic Sperm Injection

  • Ivf Using Donor Eggs


In Vitro Fertilization Devices Outlook



  • Imaging Systems

  • Sperm Separation System

  • Ovum Aspiration Pump

  • Micromanipulator

  • Cryosystem


In Vitro Fertilization Reagents Outlook



  • Embryo Culture Media

  • Cryopreservation Media

  • Sperm Processing Media

  • Ovum Processing Media


In Vitro Fertilization End User Outlook



  • Clinical Research Institutes

  • Fertility Clinics

  • Hospitals


In Vitro Fertilization Regional Outlook




  • North America








    • US




    • Canada








  • Europe








    • Germany




    • France




    • UK




    • Italy




    • Spain




    • Rest of Europe








  • Asia-Pacific




    • China




    • Japan




    • India




    • Australia




    • South Korea




    • Australia




    • Rest of Asia-Pacific






  • Rest of the World




    • Middle East




    • Africa




    • Latin America






Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.